2XS-27094-03343
3 vaccinations
8 coded responses
41 check-ins
8 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 283 / NC
- Registered
- 2021-08-11
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
XXS-13225-06339
Child or adolescent in my care · Female · 2022-01-10
CSF-19514-70501
Child or adolescent in my care · Male · 2022-01-11
Timeline
-
2021-08-11
Registered in v-safe
-
2021-08-11
Dose 1 — Moderna
- 2021-08-11
- 2021-08-12
- 2021-08-13
-
2021-08-14
Survey response — days 1–6 daily, dose 1MedDRA: Initial insomnia, Insomnia — Feeling: Good · Fever · Headache, Joint painsFree text: Difficulty falling/staying asleepMedDRA releases: 2021-09,2024-11 · check-in free text available
- 2021-08-15
- 2021-08-16
- 2021-08-17
- 2021-08-18
- 2021-08-25
- 2021-09-01
-
2021-09-08
Dose 2 — Moderna
- 2021-09-08
-
2021-09-09
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Swelling · Fever · Headache, Fatigue or tirednessAdult check-in
-
2021-09-10
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Headache, Muscle or body achesAdult check-in
- 2021-09-11
- 2021-09-12
- 2021-09-13
- 2021-09-14
- 2021-09-15
-
2021-09-22
Survey response — day 14, dose 2MedDRA: Flushing — Feeling: GoodFree text: Flushing of face/cheeks. No fever. Lasted for hours on worst dayMedDRA releases: 2024-11 · check-in free text available
-
2021-09-29
Survey response — day 21, dose 2MedDRA: Injection site dryness, Injection site pruritus, Injection site rash, Self-medication — Feeling: GoodFree text: Dry rash on arm just below injection site. Mild itching. Rectangular shape 3 inches long x 1-1.5 inches wide. Has been present following 1st injection. Not responding to lotion or hydrocortisone creamMedDRA releases: 2024-11 · check-in free text available
- 2021-10-06
- 2021-10-13
- 2021-10-20
- 2021-12-08
- 2022-03-09
-
2022-04-18
Dose 3 — Moderna
- 2022-04-18
-
2022-04-19
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain, Redness · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2022-04-20
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Headache, Joint pains, Muscle or body achesAdult check-in
-
2022-04-21
Survey response — days 1–6 daily, dose 3MedDRA: Lymph node pain, Lymphadenopathy — Feeling: Good · Site: Pain · HeadacheFree text: Swelling and pain in axillary lymph node on side of injectionMedDRA releases: 2024-11 · check-in free text available
-
2022-04-22
Survey response — days 1–6 daily, dose 3MedDRA: Lymph node pain, Lymphadenopathy — Feeling: Good · HeadacheFree text: Axillary lymph node pain and swelling on side of injectionMedDRA releases: 2024-11 · check-in free text available
- 2022-04-23
- 2022-04-24
- 2022-04-25
- 2022-05-02
- 2022-05-09
- 2022-05-16
-
2022-05-23
Survey response — day 35, dose 3MedDRA: Rash — Feeling: GoodFree text: RashMedDRA releases: 2024-11 · check-in free text available
-
2022-05-30
Survey response — day 42, dose 3MedDRA: Rash — Feeling: GoodFree text: RashMedDRA releases: 2024-11 · check-in free text available
-
2022-07-18
Survey response — 3 months, dose 3MedDRA: Pre-existing disease — Feeling: GoodFree text: Rash (chronic)MedDRA releases: 2024-11 · check-in free text available
- 2022-10-17
- 2023-04-18
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-08-11 | Moderna | No |
| 2 | 2021-09-08 | Moderna | No |
| 3 | 2022-04-18 | Moderna | No |
Free text
Release 9 — days 1–6 daily, dose 1
Systemic reaction (other): Difficulty falling/staying asleep
Release 9 — day 14, dose 2
Symptoms: Flushing of face/cheeks. No fever. Lasted for hours on worst day
Release 9 — day 21, dose 2
Symptoms: Dry rash on arm just below injection site. Mild itching. Rectangular shape 3 inches long x 1-1.5 inches wide. Has been present following 1st injection. Not responding to lotion or hydrocortisone cream
Release 11 — days 1–6 daily, dose 3
Systemic reaction (other): Swelling and pain in axillary lymph node on side of injection
Systemic reaction (other): Axillary lymph node pain and swelling on side of injection
Release 11 — day 35, dose 3
Symptoms: Rash
Release 11 — day 42, dose 3
Symptoms: Rash
Release 12 — 3 months, dose 3
Symptoms: Rash (chronic)
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Flushing | · | · | ✓ |
| SD | Injection site dryness | · | · | ✓ |
| SD | Injection site pruritus | · | · | ✓ |
| SD | Injection site rash | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SD | Rash | · | · | ✓ |
| SD | Self-medication | · | · | ✓ |
| SRO | Initial insomnia | ✓ | · | ✓ |
| SRO | Insomnia | ✓ | · | ✓ |
| SRO | Lymph node pain | · | · | ✓ |
| SRO | Lymphadenopathy | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release